Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling — Stella

View on ClinicalTrials.gov

Recruiting

Back to Obesity trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Colorado Anschutz, Aurora, Colorado

Key details

Sponsor

University of Colorado, Denver

Collaborators

National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~70 participants

Started

January 2024

Primary completion

December 2028

Age range

18 Years – 70 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.